8-K
Current Report
MoonLake Immunotherapeutics Filed Acc 0001213900-22-009481
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading ea156204-8k_helixacq.htm…